Indeed, although increased sCD163 has been described to be indicative of a lower risk of DUs [239], in a previous report sCD163 serum levels were found to be significantly elevated in SSc patients with DUs compared to those without these complications [236]. This evidence concerns the gene CD163 and systemic sclerosis.